-$0.25 Earnings Per Share Expected for Catasys, Inc. (NASDAQ:CATS) This Quarter

Wall Street analysts expect Catasys, Inc. (NASDAQ:CATS) to report ($0.25) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Catasys’ earnings. Catasys posted earnings per share of ($0.34) in the same quarter last year, which indicates a positive year-over-year growth rate of 26.5%. The business is expected to report its next quarterly earnings report on Wednesday, August 12th.

On average, analysts expect that Catasys will report full year earnings of ($0.73) per share for the current financial year. For the next financial year, analysts forecast that the business will report earnings of ($0.15) per share. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that cover Catasys.

Catasys (NASDAQ:CATS) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.45) EPS for the quarter, missing analysts’ consensus estimates of ($0.41) by ($0.04). The company had revenue of $12.34 million for the quarter.

CATS has been the topic of a number of recent analyst reports. Royal Bank of Canada initiated coverage on Catasys in a research report on Monday, April 20th. They set an “outperform” rating and a $35.00 price target on the stock. BidaskClub raised Catasys from a “hold” rating to a “buy” rating in a research report on Friday, June 19th. Canaccord Genuity reaffirmed a “buy” rating and set a $26.00 price target on shares of Catasys in a research report on Wednesday, April 15th. ValuEngine raised Catasys from a “hold” rating to a “buy” rating in a research report on Thursday, April 2nd. Finally, Zacks Investment Research raised Catasys from a “sell” rating to a “hold” rating in a research report on Wednesday, March 25th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $26.00.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Arbitrage SA increased its position in shares of Catasys by 186.2% in the 1st quarter. BNP Paribas Arbitrage SA now owns 2,810 shares of the company’s stock valued at $43,000 after acquiring an additional 1,828 shares during the period. Panagora Asset Management Inc. purchased a new stake in Catasys in the fourth quarter valued at $66,000. Barclays PLC boosted its holdings in Catasys by 84.4% in the fourth quarter. Barclays PLC now owns 7,209 shares of the company’s stock valued at $118,000 after purchasing an additional 3,299 shares during the last quarter. UBS Group AG boosted its holdings in Catasys by 32.9% in the fourth quarter. UBS Group AG now owns 9,271 shares of the company’s stock valued at $151,000 after purchasing an additional 2,297 shares during the last quarter. Finally, Citigroup Inc. boosted its holdings in Catasys by 5.4% in the first quarter. Citigroup Inc. now owns 9,858 shares of the company’s stock valued at $150,000 after purchasing an additional 507 shares during the last quarter. 20.02% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ:CATS opened at $21.53 on Wednesday. The company has a market capitalization of $366.45 million, a price-to-earnings ratio of -11.76 and a beta of 2.21. Catasys has a 52 week low of $8.55 and a 52 week high of $32.55. The firm has a 50 day moving average of $20.42 and a 200 day moving average of $18.49.

Catasys Company Profile

Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.

See Also: Understanding the different types of bonds

Get a free copy of the Zacks research report on Catasys (CATS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.